Back to News
Market Impact: 0.25

SYK Quantitative Stock Analysis

SYKNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechCapital Returns (Dividends / Buybacks)Market Technicals & Flows
SYK Quantitative Stock Analysis

Validea's guru fundamental report assigns STRYKER CORP (SYK) an 81% rating under Pim van Vliet's Multi-Factor Investor model, which targets low volatility stocks with strong momentum and high net payout yields. As a large-cap medical equipment stock, SYK passed criteria for market capitalization and low standard deviation, aligning with the model's low-risk focus, though it was neutral on momentum and net payout yield. This 81% score indicates 'some interest' from a strategy designed to achieve high returns with reduced risk, positioning SYK as a potential candidate for such conservative equity approaches.

Analysis

Stryker Corp (SYK) has been rated favorably by Validea's Multi-Factor Investor model, achieving a score of 81%, which signifies 'some interest' based on the strategy of Pim van Vliet. This quantitative model specifically seeks low-volatility stocks that also exhibit strong momentum and high net payout yields. As a large-cap company in the Medical Equipment & Supplies industry, SYK successfully passed the model's criteria for market capitalization and low standard deviation, reinforcing its position as a stable, defensive stock. However, the analysis also indicates a neutral rating for SYK on both 'Twelve Minus One Momentum' and 'Net Payout Yield.' This suggests that while SYK's risk profile is attractive under this framework, its recent price performance and capital return program are not currently strong enough to generate a high-conviction signal, resulting in a mixed but overall positive assessment.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo